PMA device
Fluency Plus Endovascular Stent Graft
Bard Peripheral Vascular, Inc. · System, Endovascular Graft, Arteriovenous (Av) Dialysis Access Circuit Stenosis Treatment (PFV, Class III) · First FDA decision Jun 17, 2014, newest Oct 5, 2017Kidney failure and dialysisVascular access
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
4
PMA pathway
Device trials
43
Naming "Fluency Plus"
MAUDE reports
1,415
Brand "Fluency Plus", since 2015
PubMed studies
0
Mentioning "Fluency Plus"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Fluency Plus Endovascular Stent Graft
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 4 of 4 decisions filed under this name.
- Fluency Plus Endovascular Stent GraftPMA supplement
P130029-S007 · Decided Oct 5, 2017 · 178 days after receipt · Normal 180 Day Track No User Fee
Device type: System, endovascular graft, arteriovenous (AV) dialysis access circuit stenosis treatment (PFV) · Cardiology
- FLUENCY PLUS ENDOVASCULAR STENT GRAFTPMA supplement
P130029-S004 · Decided Aug 24, 2016 · 194 days after receipt · Normal 180 Day Track No User Fee
Device type: System, endovascular graft, arteriovenous (AV) dialysis access circuit stenosis treatment (PFV) · Cardiology
- FLUENCY PLUS ENDOVASCULAR STENT GRAFTPMA supplement
P130029-S002 · Decided Apr 26, 2016 · 361 days after receipt · Panel Track
Device type: System, endovascular graft, arteriovenous (AV) dialysis access circuit stenosis treatment (PFV) · Cardiology
1 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Erythropoiesis Stimulating Agents (ESAs) for Treatment of Anemia in Adults with CKD Including Patients on Dialysis and Patients not on DialysisNational analysisReview closedCAG-00413NUpdated Sep 17, 2026
- Hemodialysis for Treatment of SchizophreniaNational determinationOn the books130.8Updated Dec 2, 2002
- Dialysis Access MaintenanceLocal determinationIn effectL34062CGS Administrators, LLCUpdated Feb 20, 2026
- Non-Invasive Peripheral Venous Vascular and Hemodialysis Access StudiesLocal determinationIn effectL35751WPS Insurance CorporationUpdated Feb 20, 2026
- Application of Skin Substitute Grafts for Treatment of DFU and VLU of Lower ExtremitiesLocal determinationIn effectL36377First Coast Service Options, Inc.Updated Nov 21, 2019
Clinical trials
Device studies on ClinicalTrials.gov that name "Fluency Plus", any status and sponsor, newest update first.
- Brain Stimulation Paired With Structured Reading Instruction in Children With DyslexiaEnrolling by invitation
General Neuro Inc.Not on our public-company list
NCT07762365 · 60 participants (planned) · Start Oct 5, 2026 · Primary completion Jun 1, 2031
Device: Active transcranial electrical stimulation (tES); Sham transcranial electrical stimulation (tES) · For: Dyslexia; Reading Disability
Sites: Boston, Massachusetts
Children's Hospital of PhiladelphiaAcademic, hospital or other
NCT07923370 · 40 participants (planned) · Start Oct 30, 2025 · Primary completion Aug 2027
Device: FaceSay; SuccessMaker Reading · For: Survivors of Pediatric Brain Tumors; Pediatric Cancer
Sites: Philadelphia, Pennsylvania
The University of Texas at DallasAcademic, hospital or other
NCT07354139 · 50 participants (planned) · Start Mar 17, 2026 · Primary completion Feb 28, 2027
Device: High - Definition Transcranial Direct Current Stimulation · For: Stuttering; Fluency Disorder
Sites: Richardson, Texas
40 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Fluency Plus", and for the whole product code for context.
This brand
1,415 reports: 1,270 malfunction, 138 injury, 7 death
Whole product code PFV
2,805 reports: 1,911 malfunction, 863 injury, 31 death
Newest reports for this brand
Angiomed GmbH & Co. Medizintechnik KG
9681442-2026-00250 · Received Oct 22, 2026 · Event dated Sep 29, 2026
Device type: System, Endovascular Graft, Arteriovenous (Av) Dialysis Access Circuit Stenosis Treatment (PFV)
Device problem as coded: Detachment of Device or Device Component; Activation Failure
Patient problem as coded: Foreign Body In Patient
Bard Peripheral Vascular, Inc.
2020394-2026-03117 · Received Oct 14, 2026 · Event dated Sep 23, 2026
Device type: System, Endovascular Graft, Arteriovenous (Av) Dialysis Access Circuit Stenosis Treatment (PFV)
Device problem as coded: Break; Improper or Incorrect Procedure or Method
Patient problem as coded: Foreign Body In Patient
- Fluency Plus Endovascular Stent GraftMalfunction
Bard Peripheral Vascular, Inc.
2020394-2026-03125 · Received Oct 14, 2026 · Event dated Aug 6, 2026
Device type: System, Endovascular Graft, Arteriovenous (Av) Dialysis Access Circuit Stenosis Treatment (PFV)
Device problem as coded: Positioning Failure; Material Perforation; Misfire
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Fluency Plus"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code PFV.
- GORE VIABAHN Endoprosthesis with Heparin Bioactive SurfaceW. L. Gore & Associates, Inc. · PMA 2022
- Covera Vascular Covered StentC.R. Bard, Inc. · PMA 2022
- WRAPSODY® Cell-Impermeable EndoprosthesisMerit Medical Systems, Inc. · PMA 2025
- Flair Endovascular Stent GraftBard Peripheral Vascular · PMA 2014
- Bard Flair Endovascular Stent GraftBard Peripheral Vascular · PMA 2010
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.